跳至主要内容
临床试验/IRCT20220508054780N1
IRCT20220508054780N1招募中3 期

Evaluation of therapeutic effect of baricitinib in patients with severe pneumonia requiring non-invasive ventilation induced to Covid 19

Mashhad University of Medical Sciences0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with severe covid 19 who fullfill PCR or radiological criteria for covid 19 clinical symptoms
  • History of respiratory symptoms from one week before, with a diagnosis of acute respiratory failure
  • Requires non-invasive ventilation to maintain O2 saturation above 85% in IC

排除标准

  • Increased liver enzymes and renal failure
  • Bacterial, fungal and viral infections
  • Bone marrow suppression and decrease in leukocytes

研究者

相似试验